MARTEN STEEN

Profile

First Name

: MARTEN

Middle Name

:

Last Name

: STEEN

Related Companies
Titles
Company Name
Related People
DIRECTOR
FERROKIN BIOSCIENCES INC
BRYANT E. FONG, DENNIS HENNER, PH.D., HUGH Y. RIENHOFF, JR., HUGH Y. RIENHOFF, JR., M.D.
DIRECTOR
ULTRAGENYX PHARMACEUTICAL INC.
BILL ALISKI, WILLIAM ALISKI, BEN AUSPITZ, JOHN DITTON, STEVEN JUNGLES, EMIL KAKKIS, EMIL D. KAKKIS, THOMAS KASSBERG, JOHN KLOCK, CORDELIA LEONARD, ERAN NADAV, SHALINI SHARP, JENNY SORIANO, VIMAL SRIVASTAVA
DIRECTOR
HEALTHCAP VI, L.P.
JOHAN CHRISTENSON, ANKI FORSBERG, JACOB GUNTERBERG, N/A HEALTHCAP VI GP S.A., FRANCOIS KAISER, STAFFAN LINDSTRAND, BJORN ODLANDER, DAG RICHTER, PER SAMUELSSON, DANIEL SCHAFER
DIRECTOR
CORTENDO AB
FREDRIC COHEN, A. BRIAN DAVIS, A. BRIAN DAVIS, BRIAN DAVIS, ERNEST EICHENBERG III, JOHN JOHNSON, JOHN H. JOHNSON, ESPEN TIDEMANN JORGENSEN, RICHARD KOLLENDER, GARHENG KONG, ALEXANDER LINDSTROM, STEPHEN LONG, STEVE LONG, ROBERT LUTZ, JOSEPH M. MAHADY, MATTHEW PAULS, H. JOSEPH REISER, JEFFREY W. SHERMAN, EIGIL STRAY SPETALEN, HILDE H. STEINEGER, RUTH THIEROFF-EKERDT
DIRECTOR
VAXIN INC.
DAVID DRUTZ, WILLIAM ENRIGHT, FLORENT GROS, PHILIP HODGES, PHILIPPE POULETTY, SCOT ROBERTS, KLAUS SCHAFER
DIRECTOR
STRONGBRIDGE BIOPHARMA PLC
FREDRIC COHEN, A. BRIAN DAVIS, A. BRIAN DAVIS, BRIAN DAVIS, ERNEST EICHENBERG III, JOHN JOHNSON, JOHN H. JOHNSON, ESPEN TIDEMANN JORGENSEN, RICHARD KOLLENDER, GARHENG KONG, ALEXANDER LINDSTROM, STEPHEN LONG, STEVE LONG, ROBERT LUTZ, JOSEPH M. MAHADY, MATTHEW PAULS, H. JOSEPH REISER, JEFFREY W. SHERMAN, EIGIL STRAY SPETALEN, HILDE H. STEINEGER, RUTH THIEROFF-EKERDT
DIRECTOR
HEALTHCAP VII, L.P.
JOHAN CHRISTENSON, ANKI FORSBERG, N/A HEALTHCAP VII GP S.A., BJORN ODLANDER, PER SAMUELSSON, DANIEL SCHAFER
DIRECTOR
BIOCLIN THERAPEUTICS, INC.
STEVE ABELLA, FOUAD AZZAM, THOMAS BOONE, GRAEME CURRIE, JULIE M. EASTLAND, ERIC EMERY, BRENT D. FASSETT, CORY FREEDLAND, JOCELYN HOLASH, JOEL JEAN-MAIRET, DAVID KABAKOFF, STEPHEN LAU, STEPHEN W. LAU, PETER MOLDT, SCOTT D. MYERS, JACK NIELSEN, CHRISTIAN RICHARD, KENNETH SCHWARTZ, MARTIN STEEN, JOSEPH L. TURNER, ERIC YUEN
DIRECTOR
RAINIER THERAPEUTICS, INC.
STEVE ABELLA, FOUAD AZZAM, THOMAS BOONE, GRAEME CURRIE, JULIE M. EASTLAND, ERIC EMERY, BRENT D. FASSETT, CORY FREEDLAND, JOCELYN HOLASH, JOEL JEAN-MAIRET, DAVID KABAKOFF, STEPHEN LAU, STEPHEN W. LAU, PETER MOLDT, SCOTT D. MYERS, JACK NIELSEN, CHRISTIAN RICHARD, KENNETH SCHWARTZ, MARTIN STEEN, JOSEPH L. TURNER, ERIC YUEN
DIRECTOR
ARO BIOTHERAPEUTICS CO
ELIZABETH ANDERSON, SUSAN B DILLON, MITTIE DOYLE, SAAN-CHIRAG GANDHI, SCOTT GREENBERG, DANIEL JANSE, MARK LAURENZI, MARK V. LAURENZI, JESS LIFTON, CHRISTOPHER MIRABELLI, KARYN O-NEIL, BRUCE PEACOCK, KEVIN RAIDY
DIRECTOR
MAHZI THERAPEUTICS INC.
STEPHEN FARR, CAMILLE SAMUELS, SHALINI SHARP, YAEL WEISS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-07-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-07 
2022-12-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-13 
2022-11-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-07 
2021-12-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2021-10-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-07 
2021-06-11
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2021-04-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2021-01-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2019-07-26
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-07-16 
2019-02-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-01-30 
2018-05-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-06 
2017-03-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-06 
2016-12-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NOT APPLICABLE 
Equity 
2016-12-22 
2016-06-29
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2015-08-06 
2015-09-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2015-08-28 
2015-07-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-29 
2015-03-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-10 
2015-03-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-10 
2015-02-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-10 
2013-01-25
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2011-04-07 
2012-12-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-18 
2012-07-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-16 
2012-04-04
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2011-04-07 
2012-02-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-10 
2011-06-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-16 
2010-06-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-03